Cancer in Primary Care
The Primary Cancer Research Group was established at the University of Melbourne in 2013 and has become the biggest primary care cancer research team in the world. The team has accrued over $30,000,000 of funding and published over 160 publications since 2018. The research group has steadily grown and currently includes over 30 core team members working in three distinct areas:
*Data linkage – linking primary care data to hospital and clinical cancer registries to study the patterns of care and impacts on patient outcomes, as part of a Victorian Comprehensive Cancer Centre (VCCC) Alliance research program.
*Clinical trials – we are currently running nine randomized controlled trials (RCTs) in general practice testing novel interventions covering cancer prevention, risk-based screening, pharmacogenomics, and early cancer diagnosis in primary care.
*Primary care trial infrastructure and capacity building – the Primary Care Collaborative Cancer Clinical Trials Group (PC4) and PARTNER national trial networks.
The evolution and growth of the team reflects the success in obtaining competitive research funding through effective national and international collaboration, and development of effective teams to execute research.
At a local level, the Primary Care Cancer Research Group has built strong collaborations with researchers from the School of Population and Global Health (Mark Jenkins, John Hopper), the School of Medicine (Finlay Macrae, Ingrid Winship), and the Department of General Practice (Jo-Anne Manski-Nankervis, Dougie Boyle, Lena Sanci, Patty Chondros). These collaborations have been critical to build programs on cancer genomics and risk-based prevention, creation of critical data infrastructure for data linkage and trials, and development of decision support tools.
Nationally, we work closely with research teams at the University of Western Australia, University Technology Sydney, University of Queensland, University of Sydney, Flinders University, and others. Many of these collaborations have been built through the successful engagement and processes established by PC4 (see below).
Internationally, we have a long-standing collaboration with researchers at the University of Cambridge as part of our program on cancer risk assessment and early detection. This led to our group being the Australian lead on the £5 million Cancer Research UK Cantest program, creating opportunities for our team to attend international research schools on early cancer diagnosis and develop collaborations with groups in the UK (Cambridge, UCL, Exeter, Oxford), the US and Denmark. Jon Emery and PC4 were approached to help establish primary care cancer networks in SE Asia, led through a collaboration at NUS in Singapore. The SPRINT (Singapore) and Asia Pacific Primary Care Cancer Research Group have been established and have led to collaborations on several Australian and Asian grants involving early and mid-career researchers. This is supported through the Primary Care Collaborative Cancer Clinical Trials Group (PC4) of which Prof Jon Emery is Director.
PC4- The Primary Care Collaborative Cancer Clinical Trials Group
PC4 is funded by Cancer Australia to support the development of high-quality cancer research in primary care. Our Group provides an infrastructure to foster collaboration between researchers, health care practitioners, policy makers and consumers. We provide access to expert advice and resources through our Support Services, and build research capacity with our Training Awards, Workshops and Mentoring Programs. Further information about becoming a member of PC4 and learning more about ways to support your research is provided on the trial group’s website.
The PARTNER network is a national rural practice-based research network (PBRN) that connects rural Australians to potential clinical trials through their local GP. PARTNER creates an environment of research-ready GP practices that improves the efficiency and quality of trials conducted in primary care. PARTNER uses technology solutions to support identification of eligible patients for trials, for disease surveillance and trial follow-up.
For more information, please see: https://pursuit.unimelb.edu.au/articles/bringing-clinical-trials-to-regional-patients.
Dr. Rebecca Bergin – Honorary Fellow
Ms. Rachel Brooks – Research Support Nurse
Ms. Aradhana Chandra – Administration Officer
Ms. Sophie Chima – PhD Candidate/ Research Assistant
Dr. Deborah De Guingand – National Manager, IC3
Ms. Allison Drosdowsky – PhD Candidate/ Statistician
Dr. Jon Emery – Herman Chair of Primary Care Cancer Research, Director, PC4
Ms. Floriana La Rocca - Program Manager, Primary Care Trials Unit
Dr. Alex Lee - Research Fellow in Cancer Services and Data Science
Dr. Shaoke Lei – Research Fellow
Ms. Jamie Liew – Research Support Officer
Mr. Philip Ly – Research Assistant
Dr. Javiera Martinez-Gutierrez – Research Fellow
Dr. Jennifer McIntosh - Academic Specialist
Ms. Tarryn Miles - Research Assistant
Dr. Kristi Milley – National Manager, PC4
Mrs. Shakira Milton – Phd Candidate/Research Assistant
Ms. Sarah Nagorcka – Communications Coordinator
Ms. Sally Philip – Program Manager, VCCC Data-Driven Research Hub
Ms. Katerina Piakis - Research Assistant
Mr. Greg Poynter - Program Manager, PARTNER
Dr. Meena Rafiq - Research Fellow
Ms. Georgia Ramsay – Research Assistant
Dr. Sibel Saya – Research Fellow / Trials Coordinator
Ms. Silja Schrader – Health Data Analyst
Mr. Raushaan Seychell – ResearchAssistant
Ms. Zoe Siviour – Research Assistant
Mr. Matthew Thoenig - Research Officer
Dr. Brent Venning – Academic Registrar
Ms. Olivia Wawryk – Data Analyst, VCCC Data-Driven Research Hub
Ms. Anna Wood – Project Manager, SMARTscreen
Dr. Jianrong Zhang – PhD Candidate
Prof Jon Emery and his team have long-standing collaborations with researchers around the world in primary care, cancer, psychiatry, genomics, and linked data. These include a program of work with Prof Fiona Walter now at Queen Mary University of London (Wolfson Institute of Population Health) and formerly at the Department of Public Health and Primary Care, University of Cambridge, Dr Chad Bousman at the University of Calgary on the PRESIDE trial, and Dr Juliet Usher-Smith at Cambridge on the CanRisk program. Additionally, The CanTest program, co-led by Prof Fiona Walter and Prof Willie Hamilton encompassed 42 collaborators from 11 institutions around the world with a focus on early cancer detection in primary care. Current studies within this collaboration include SCRIPT, CRISP, IC3, CanRisk and the Melatools programme.
Other collaborators include:
- Department of Health Victoria
- Cancer Council of Australia
- Cancer Council of Victoria
- Victorian Comprehensive Cancer Centre
- Health and Biomedical Informatics Centre, University of Melbourne
- Centre for Epidemiology and Biostatistics, University of Melbourne
- Royal Melbourne Hospital
- Western Health
- Peter MacCallum Cancer Centre
- Department of Public Health and Primary Care, University of Cambridge
- Department of General Practice, University of Sydney
- Department of General Practice, Monash University
- Department of Medicine, University of Western Australia
Our research is funded by the National Health and Medical Research Council (NHMRC), Cancer Australia, Cancer Council Victoria, Department of Health Victoria, Medical Research Future Fund (MRFF), Victorian Cancer Agency, the VCCC Alliance, Cancer Research UK, Paul Ramsay Foundation and the BUPA Foundation.
Research Publication Highlights from the Cancer Research Group:
Drosdowsky, A., Lamb, K. E., Bergin, R. J., Boyd, L., Milley, K., IJzerman, M. J., & Emery, J. D. (2023). A systematic review of methodological considerations in time to diagnosis and treatment in colorectal cancer research. Cancer Epidemiology, 83, 102323.
Emery, J., Jenkins, M. A., Saya, S., Chondros, P., Oberoi, J., Milton, S., ... & McIntosh, J. G. (2023). The CRISP Trial: RCT of a decision support tool for risk-stratified colorectal cancer screening. British Journal of General Practice.
Milley, K., Chima, S., Karnchanachari, N., McNamara, M., Druce, P., & Emery, J. (2023). General practice-based cancer research publications: a bibliometric analysis 2013–2019. British Journal of General Practice, 73(727), e133-e140.
Milley, K., Chima, S., McIntosh, J. G., Ackland, E., & Emery, J. D. (2021). Long‐term consumer involvement in cancer research: Working towards partnership. Health Expectations, 24(4), 1263-1269.
Milley, K., Chima, S., Thornton-Benko, E., & Emery, J. (2022). Embedding primary healthcare professionals as consumers in cancer research development. Australian Journal of General Practice, 51(8), 565-566.
Milton, S., McIntosh, J., Macrae, F., Chondros, P., Trevena, L., Jenkins, M., ... & Emery, J. (2021). An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial. Trials, 22(1), 1-17.
Ristanoski, G., Emery, J., Martinez Gutierrez, J., McCarthy, D., & Aickelin, U. (2021, February). Handling uncertainty using features from pathology: opportunities in primary care data for developing high risk cancer survival methods. In 2021 Australasian Computer Science Week Multiconference (pp. 1-7).
Ristanoski, G., Emery, J., Gutierrez, J. M., McCarthy, D., & Aickelin, U. (2022). AI based cancer detection models using primary care datasets. Journal of Advances in Information Technology Vol, 13(2).
Saya, S., Boyd, L., Chondros, P., McNamara, M., King, M., Milton, S., ... & Emery, J. (2022). The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care. Trials, 23(1), 810.
Wood, A., Emery, J. D., Jenkins, M., Chondros, P., Campbell, T., Wenkart, E., ... & McIntosh, J. G. (2022). The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program. Trials, 23(1), 1-14.
Zhang, J., IJzerman, M. J., Oberoi, J., Karnchanachari, N., Bergin, R. J., Franchini, F., ... & Emery, J. D. (2022). Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer, 166, 27-39.
Zhang, J., Oberoi, J., Karnchanachari, N., Druce, P., IJzerman, M. J., & Emery, J. D. (2021). The timeliness of lung cancer care: A systematic review of systematic/scoping reviews on time intervals and their impacts on cancer outcomes.
Please click here to view a complete citations list from the Cancer Research Group spanning over 220 publications since 2018.
- SCRIPT Trial: A Randomised Controlled Trial utilising a genomic test as an intervention providing personalised bowel cancer screening information
- PRESIDE Trial: A Randomised Controlled Trial providing antidepressant medication information to patients with mild-to-severe depressive symptoms.
- MAGPIE Study: A genomic test intervention designed to provide patients with personalised melanoma, bowel, breast, and prostate cancer screening information
- SMARTScreen: Utilisation of an SMS intervention with evocative videos sent to GP patients who are overdue in their bowel cancer screening
- SMARTERScreen: A Randomised Controlled Trial based on evidence from SMARTScreen utilising SMS messages to prompt patients overdue with bowel cancer screening
- IC3 Trial: A Randomised Control Trial aiming to improve early diagnosis of liver cancer and improving patient health outcomes
- CANARY (CANcer risk in patients with unexpected weight loss in primaRY care) Studies: Clinical Decision Support Systems for Cancer Prevention and Early Cancer Detection in Primary Care
- SITA (Should I Take Aspirin?) Trial: A Randomised Control Trial of a decision aid to support informed choices about taking aspirin to prevent cancer and other chronic disease.
- Algorithms For Early Detection of Cancer Using Linked Primary Care Data
Faculty Research Themes
School Research Themes
Department / Centre
Unit / Centre
MDHS Research library
Explore by researcher, school, project or topic.